High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma is a research paper published in Science Advances (2020). On theSindex it has a DataRank of 0. It has been cited 64 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U54CA198999-05
NCI NIH HHS
Grant: R01 CA215075
NCI NIH HHS
Grant: U54 CA198999
NCI NIH HHS
Grant: P30 CA016086
NCI NIH HHS
Grant: T32 CA196589
FWCI
3.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
Additional file 1 of Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment